Puleo, M.; Pafumi, S.; Di Pietro, M.; Ricciardi, G.R.R.; Sanò, M.V.
Sustained Complete Response to Trastuzumab Deruxtecan Beyond Treatment Discontinuation in a Heavily Pretreated HER2-Positive Breast Cancer Patient with Skin Metastases: A Case Report. Reports 2025, 8, 126.
https://doi.org/10.3390/reports8030126
AMA Style
Puleo M, Pafumi S, Di Pietro M, Ricciardi GRR, Sanò MV.
Sustained Complete Response to Trastuzumab Deruxtecan Beyond Treatment Discontinuation in a Heavily Pretreated HER2-Positive Breast Cancer Patient with Skin Metastases: A Case Report. Reports. 2025; 8(3):126.
https://doi.org/10.3390/reports8030126
Chicago/Turabian Style
Puleo, Maria, Sarah Pafumi, Martina Di Pietro, Giuseppina Rosaria Rita Ricciardi, and Maria Vita Sanò.
2025. "Sustained Complete Response to Trastuzumab Deruxtecan Beyond Treatment Discontinuation in a Heavily Pretreated HER2-Positive Breast Cancer Patient with Skin Metastases: A Case Report" Reports 8, no. 3: 126.
https://doi.org/10.3390/reports8030126
APA Style
Puleo, M., Pafumi, S., Di Pietro, M., Ricciardi, G. R. R., & Sanò, M. V.
(2025). Sustained Complete Response to Trastuzumab Deruxtecan Beyond Treatment Discontinuation in a Heavily Pretreated HER2-Positive Breast Cancer Patient with Skin Metastases: A Case Report. Reports, 8(3), 126.
https://doi.org/10.3390/reports8030126
